Guided Therapeutics (GTHP) Cost of Revenue (2010 - 2025)
Guided Therapeutics recorded quarterly Cost of Revenue of $105000.0 in Q4 2025, up 377.27% quarter-over-quarter from $22000.0 in Q3 2025, and up 149.3% year-over-year from $42118.6 in Q4 2024.
Guided Therapeutics' Cost of Revenue history runs 16 years deep, the most recent figure standing at $105000.0 for Q4 2025.
- In Q4 2025, Cost of Revenue rose 149.3% year-over-year to $105000.0; the TTM figure through Dec 2025 stood at $251000.0 (up 218.96% YoY), while the FY2025 annual figure was $169000.0, up 3280.0% from the prior year.
- Cost of Revenue came in at $105000.0 for Q4 2025 at Guided Therapeutics, up from $22000.0 in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $222000.0 in Q4 2023 to a low of -$213000.0 in Q4 2024.
- A 5-year average of $28117.6 and a median of $37000.0 in 2022 frame the typical range for Cost of Revenue.
- Across the five-year window, Cost of Revenue sank 380.0% in 2022 and jumped 3550.0% in 2025, its largest moves.
- Guided Therapeutics' Cost of Revenue stood at -$10000.0 in 2021, then tumbled by 380.0% to -$48000.0 in 2022, then soared by 562.5% to $222000.0 in 2023, then tumbled by 195.95% to -$213000.0 in 2024, then jumped by 149.3% to $105000.0 in 2025.
- According to Business Quant data, Cost of Revenue over the past three periods registered $105000.0, $22000.0, and $51000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.89 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 2.21 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 3.26 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 1.59 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 362.60 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 2.51 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 441.60 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 481.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 891.20 Mn |
| 10 | Guided Therapeutics | - | - | 458,000.00 | 105,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 105,000.00 |
| Dec 31, 2025 | 105,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Sep 30, 2025 | 22,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Jun 30, 2025 | 51,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | -213,000.00 |
| Dec 31, 2024 | -213,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Mar 31, 2024 | 2,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Dec 31, 2023 | 222,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Sep 30, 2023 | 4,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Jun 30, 2023 | 61,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Mar 31, 2023 | 9,000.00 |
| Dec 31, 2022 | -48,000.00 |
| Dec 31, 2022 | -48,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Sep 30, 2022 | 52,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Jun 30, 2022 | 37,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Mar 31, 2022 | 40,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Dec 31, 2021 | -10,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Sep 30, 2021 | 41,000.00 |
| Jun 30, 2021 | 30,000.00 |
| Jun 30, 2021 | 30,000.00 |
| Dec 31, 2020 | 120,000.00 |
| Dec 31, 2020 | 120,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Sep 30, 2020 | 12,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Jun 30, 2020 | 6,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Mar 31, 2020 | 34,000.00 |
| Dec 31, 2019 | -21,000.00 |
| Dec 31, 2019 | -21,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Jun 30, 2019 | 21,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Mar 31, 2019 | 45,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Dec 31, 2018 | 39,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Jun 30, 2018 | 55,000.00 |
| Mar 31, 2018 | 62,000.00 |
| Mar 31, 2018 | 62,000.00 |
| Dec 31, 2017 | 58,000.00 |
| Dec 31, 2017 | 58,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Sep 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Jun 30, 2017 | 67,000.00 |
| Mar 31, 2017 | 82,000.00 |
| Mar 31, 2017 | 82,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Dec 31, 2016 | 98,000.00 |
| Sep 30, 2016 | 92,000.00 |
| Sep 30, 2016 | 92,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Jun 30, 2016 | 86,000.00 |
| Mar 31, 2016 | 68,000.00 |
| Mar 31, 2016 | 68,000.00 |
| Dec 31, 2015 | 174,000.00 |
| Dec 31, 2015 | 174,000.00 |
| Sep 30, 2015 | 187,000.00 |
| Sep 30, 2015 | 187,000.00 |
| Jun 30, 2015 | 207,000.00 |
| Jun 30, 2015 | 207,000.00 |
| Mar 31, 2015 | 107,000.00 |
| Mar 31, 2015 | 107,000.00 |
| Dec 31, 2014 | 441,000.00 |
| Dec 31, 2014 | 441,000.00 |
| Sep 30, 2014 | 135,000.00 |
| Sep 30, 2014 | 135,000.00 |
| Jun 30, 2014 | 345,000.00 |
| Jun 30, 2014 | 345,000.00 |
| Mar 31, 2014 | 192,000.00 |
| Mar 31, 2014 | 192,000.00 |
| Dec 31, 2013 | 293,000.00 |
| Dec 31, 2013 | 293,000.00 |
| Sep 30, 2013 | 117,000.00 |
| Sep 30, 2013 | 117,000.00 |
| Jun 30, 2013 | 195,000.00 |
| Jun 30, 2013 | 195,000.00 |
| Mar 31, 2013 | 164,000.00 |
| Mar 31, 2013 | 164,000.00 |
| Dec 31, 2012 | 153,000.00 |
| Dec 31, 2012 | 153,000.00 |
| Sep 30, 2012 | 132,000.00 |
| Sep 30, 2012 | 132,000.00 |
| Jun 30, 2012 | 75,000.00 |
| Jun 30, 2012 | 75,000.00 |
| Mar 31, 2012 | 70,000.00 |
| Mar 31, 2012 | 70,000.00 |
| Dec 31, 2011 | -94,000.00 |
| Dec 31, 2011 | -94,000.00 |
| Sep 30, 2011 | 80,000.00 |
| Sep 30, 2011 | 80,000.00 |
| Jun 30, 2011 | 71,000.00 |
| Jun 30, 2011 | 71,000.00 |
| Mar 31, 2011 | 49,000.00 |
| Mar 31, 2011 | 49,000.00 |
| Jun 30, 2010 | 44,000.00 |
| Jun 30, 2010 | 44,000.00 |